繁体中文
设为首页
加入收藏

About Avastin

2009-11-29 12:27:10  作者:新特药房  来源:中国新特药网  浏览次数:518  文字大小:【】【】【
简介: Avastin is a vascular endothelial growth factor-specific angiogenesis inhibitor indicated for the treatment of:Metastatic colorectal cancer, with intravenous 5-fluorouracil–based chemothe ...
关键字:About Avastin
 Avastin is a vascular endothelial growth factor-specific angiogenesis inhibitor indicated for the treatment of:Metastatic colorectal cancer, with intravenous 5-fluorouracil–based chemotherapy for first- or second-line treatment.

 

  • Non-squamous non-small cell lung cancer, with carboplatin and paclitaxel for first line treatment of unresectable, locally advanced, recurrent or metastatic disease.

  • Metastatic breast cancer, with paclitaxel for treatment of patients who have not received chemotherapy for metastatic HER2-negative breast cancer.

    • Effectiveness based on improvement in progression-free survival. No data available demonstrating improvement in disease-related symptoms or survival with Avastin.

    • Not indicated for disease progression following anthracycline and taxane chemotherapy administered for metastatic disease.

  • Glioblastoma, as a single agent for patients with progressive disease following prior therapy.

    • Effectiveness based on improvement in objective response rate. No data available demonstrating improvement in disease-related symptoms or survival with Avastin.

  • Metastatic renal cell carcinoma with interferon alfa

BOXED Warnings and Additional Important Safety Information

People receiving Avastin may experience side effects. In clinical trials, some people treated with Avastin experienced serious and sometimes fatal side effects, including:

Gastrointestinal (GI) perforation: Treatment with Avastin can result in the development of a potentially serious side effect called GI perforation, which is the development of a hole in the stomach, small intestine, or large intestine. In clinical trials, this event occurred in more people who received Avastin than in the comparison group (0.3% to 2.4%). In some cases, GI perforation resulted in fatality. Avastin therapy should be permanently stopped if GI perforation occurs.

Surgery and wound healing problems: Treatment with Avastin can lead to slow or incomplete wound healing (for example, when a surgical incision has trouble healing or staying closed). In some cases, this event resulted in fatality. Surgery and wound healing problems occurred more often in people who received Avastin than in the comparison group. Avastin therapy should not be started for at least 28 days after surgery and until the surgical wound is fully healed. The length of time between stopping Avastin and having voluntary surgery without the risk of having surgery and wound healing problems has not been determined. Treatment with Avastin should be stopped at least 28 days before voluntary surgery and in people with surgery and wound healing problems that require medical treatment.

Severe bleeding: Treatment with Avastin can result in serious bleeding, including coughing up blood, bleeding in the stomach, vomiting of blood, bleeding in the brain, nosebleeds, and vaginal bleeding. These events occurred up to 5 times more often in people who received Avastin. Across cancer types, 1.2% to 4.6% of people who received Avastin experienced severe to fatal bleeding. People who have recently coughed up blood (greater than or equal to a half teaspoon of red blood) or have serious bleeding should not receive Avastin. Treatment with Avastin should be permanently stopped if serious bleeding occurs (ie, requiring medical attention).

In clinical trials for different cancer types, there were additional serious and sometimes fatal side effects that occurred in more people who received Avastin than in those in the comparison group. The formation of an abnormal passage from parts of the body to another part (non-GI fistula formation) was seen in 0.3% or less of people. Severe to life-threatening stroke or heart problems were seen in 2.4% of people. Too much protein in the urine, which led to kidney problems, was seen in less than 1% of people. Additional serious side effects that occurred in more people who received Avastin than those in the comparison group included severe to life-threatening high blood pressure, which was seen in 5% to 18% of people, and nervous system and vision disturbances (reversible posterior leukoencephalopathy syndrome), which was seen in less than 0.1% of people. Infusion reactions with the first dose of Avastin were uncommon and occurred in less than 3% of people, and severe reactions occurred in 0.2% of people.

Common side effects that occurred in more than 10% of people who received Avastin for different cancer types, and at least twice the rate of the comparison group, were nosebleeds, headache, high blood pressure, inflammation of the nose, too much protein in the urine, taste change, dry skin, rectal bleeding, tear production disorder, back pain, and inflammation of the skin (exfoliative dermatitis). Across all trials, treatment with Avastin was permanently stopped in 8.4% to 21% of people because of side effects.

Avastin may impair fertility. If you are pregnant or thinking of becoming pregnant, talk with your doctor about the potential risk of loss of the pregnancy or the potential risk of Avastin to the fetus during and following Avastin therapy, and the need to continue an effective birth control method for at least 6 months following the last dose of Avastin.

责任编辑:admin


相关文章
Avastin(贝伐单抗)获批用于治疗胶质母细胞瘤
Avastin(bevacizumab)-贝伐珠单抗注射液
贝伐单抗注射剂AVASTIN(BEVACIZUMAB Vial,阿瓦斯汀)
阿瓦斯汀,贝伐单抗注射液(BEVACIZUMAB AVASTIN)
Avastin在眼科应用的研究进展
贝伐单抗(Avastin)治疗非小细胞肺癌
阿瓦斯汀,阿瓦司汀注射剂|AVASTIN(BEVACIZUMAB)
AVASTIN(阿瓦斯汀BEVACIZUMAB)注射剂
糖尿病黄斑水肿的治疗
安维汀〈阿瓦斯汀〉临床应用疑难相关问题解答
安维汀(贝伐珠单抗)可有效治疗晚期卵巢癌
 

最新文章

更多

· JAKAFI(ruxolitinib)片
· 凯美纳(盐酸埃克替尼片)...
· 特罗凯TARCEVA(埃罗替尼...
· 多吉美NEXAVAR(索拉非尼...
· 维康达(替吉奥胶囊)—...
· 蒂清-首个治疗脑胶质瘤的...
· 安维汀--结直肠癌的新型...
· 福达华--治疗慢淋白血病...
· 雷替曲塞粉针(Raltitre...
· 灌注中药针剂华蟾素注射...

推荐文章

更多

· JAKAFI(ruxolitinib)片
· 凯美纳(盐酸埃克替尼片)...
· 特罗凯TARCEVA(埃罗替尼...
· 多吉美NEXAVAR(索拉非尼...
· 维康达(替吉奥胶囊)—...
· 蒂清-首个治疗脑胶质瘤的...
· 安维汀--结直肠癌的新型...
· 福达华--治疗慢淋白血病...
· 雷替曲塞粉针(Raltitre...
· 灌注中药针剂华蟾素注射...

热点文章

更多